Vesugen
Lys-Glu-Asp · KED · Vascular bioregulator
Think of it as a tune-up for your blood vessels.
Vesugen is like a mechanic for your blood vessels, helping them run smoother and potentially last longer. It's a synthetic peptide that's been crafted to communicate directly with the cells lining your blood vessels. The idea is that by getting inside these cells, Vesugen can encourage them to express genes that keep everything in good working order.
Most of the research comes from the Khavinson group, who have looked at how Vesugen might influence aging blood vessels, at least in lab settings and animal studies. They've observed changes that suggest healthier blood vessel function, although it's still early days for understanding how this might apply to humans in the long run.
Who it's for
- People interested in maintaining vascular health as they age
- Biohackers curious about cutting-edge longevity research
- Individuals exploring non-mainstream approaches to wellness
Probably not for you if…
- Those looking for FDA-approved treatments
- People expecting immediate, well-documented results
- Individuals uncomfortable with experimental therapies
Editorial summary for research context · Not medical advice
Mechanism of Action
Vesugen is a synthetic tripeptide (Lys-Glu-Asp) designed as a vascular-tissue bioregulator. Khavinson-group research proposes that short peptides penetrate the cell membrane, enter the nucleus, and modulate tissue-specific gene expression — in this case in vascular endothelial cells and smooth muscle. Preclinical work has focused on endothelial markers and vascular-aging endpoints. Not FDA-approved. Preclinical and limited clinical data from Khavinson group.
Researched Benefits
Vascular endothelial gene modulation
Khavinson-lab studies report modulation of gene expression relevant to endothelial cell markers and vascular homeostasis pathways.
- [Khavinson et al. 2013]
Preclinical vascular-aging research
Russian-language studies have examined vascular morphology and endothelial function endpoints in aged rodent models.
- [Kuznik et al. 2014]
Endothelial cell-culture activity
In-vitro work on endothelial cell cultures has examined effects on proliferation and aging markers.
Research Protocols
The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.
Intranasal research protocol
- Dosage
- 100 mcg
- Frequency
- once daily
- Timing
- morning
- Cycle
- 3 weeks
Khavinson-group protocols have typically used 20-30 day cycles, repeated 2x per year.
Reported Side Effects
- No significant adverse events reported in published Khavinson-group studies
- Transient local irritation with intranasal administration
- Long-term human safety data limited
Contraindications
- Pregnancy and lactation (no safety data)
- Active vascular malignancy (theoretical concern)
- Individual hypersensitivity to peptide components
Stacking Partners
Peptides commonly paired with Vesugen in published research and protocol write-ups.
Vendor Pricing
Stacked earns a commission on purchases via these links. It does not influence our Trust Scores.
Top Videos
Curated from YouTube — refreshed weekly. Stacked doesn't host or endorse external content.
The Future of Human Healing - Vesugen (The Stem Cell Activation Peptide)
Peptide Science Institute
1 year ago
My Favorite Bioregulator Peptide for Liver Support - Ovagen
Elwin Robinson
2 years ago
Doctor Explains 10 Most Fascinating Peptides
This Is Not Covered - Dr. Ashley Froese
7 months ago
How You Can Use Peptides to Improve Your Vision
DrAndyRosenfarb
1 year ago
Epitalon: Destroy Cancer Cells, Reverse Aging, & Maximize Longevity with Peptides
Peptide Science Institute
1 year ago
Research Papers
Peptide regulation of vascular endothelium: short peptides and gene expression
Khavinson VKh, Linkova NS, et al. · Bulletin of Experimental Biology and Medicine · 2013
Peptidergic regulation of cardiovascular functions in aging
Kuznik BI, et al. · Advances in Gerontology · 2014